Search Within

Shyamprasad Deraje Vasudeva

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (1)
Groups
  1. Biostatistics Service (4)
  2. Department of Medicine (4)
  3. Department of Pathology and Laboratory Medicine (4)
  4. Epidemiology and Biostatistics (4)
  5. GSK Faculty (4)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)

More Groups

People
  1. Ian Ganly (3)
  2. James Fagin (3)
  3. Luc Morris (3)
  4. Ronald Ghossein (3)
  5. Timothy Chan (3)
  6. Venkatraman Seshan (3)

More People

Years
  1. 2018 (2)
  2. 2017 (1)
  3. 2013 (1)
Publications
  1. Cancer Cell (1)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. Lancet Oncology (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Cell Press (1)
  3. Elsevier Science, Inc. (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated genomic analysis of Hurthle cell carcinoma reveals TMEM233/PRKAB1 fusion as a novel oncogenic driver
    Meeting Abstract

    Dong, Y.; Ganly, I.; Makarov, V.; Kuo, F.; Deraje, S.; Reznik, E.; Seshan, V.; Nanjangud, G.; Morris, L.; Riaz, N.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Integrated genomic analysis of Hürthle cell cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes
    Journal Article

    Ganly, I.; Makarov, V.; Deraje, S.; Dong, Y.; Reznik, E.; Seshan, V.; Nanjangud, G.; Eng, S.; Bose, P.; Kuo, F.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Genomic alterations in fatal forms of non-anaplastic thyroid cancer: Identification of MED12 and RBM10 as novel thyroid cancer genes associated with tumor virulence
    Journal Article

    Ibrahimpasic, T.; Xu, B.; Landa, I.; Dogan, S.; Middha, S.; Seshan, V.; Deraje, S.; Carlson, D. L.; Migliacci, J.; Knauf, J. A.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial
    Journal Article

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S. M.; Reed, D. R.; Okuno, S. H.; more...
    Lancet Oncology (2013)

    Fulltext@MSK | Save